Bruush Oral Care Stock EBITDA
Bruush Oral Care fundamentals help investors to digest information that contributes to Bruush Oral's financial success or failures. It also enables traders to predict the movement of Bruush Stock. The fundamental analysis module provides a way to measure Bruush Oral's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bruush Oral stock.
Bruush |
Bruush Oral Care Company EBITDA Analysis
Bruush Oral's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Bruush Oral EBITDA | (10.49 M) |
Most of Bruush Oral's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bruush Oral Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Bruush Oral Care reported earnings before interest,tax, depreciation and amortization of (10.49 Million). This is 100.69% lower than that of the Personal Care Products sector and 100.44% lower than that of the Consumer Staples industry. The ebitda for all United States stocks is 100.27% higher than that of the company.
Bruush EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bruush Oral's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bruush Oral could also be used in its relative valuation, which is a method of valuing Bruush Oral by comparing valuation metrics of similar companies.Bruush Oral is currently under evaluation in ebitda category among its peers.
Bruush Fundamentals
Profit Margin | (2.57) % | |||
Operating Margin | (5.29) % | |||
Number Of Shares Shorted | 2.15 K | |||
Revenue | 2.63 M | |||
EBITDA | (10.49 M) | |||
Net Income | (8.77 M) | |||
Total Debt | 2.59 M | |||
Current Ratio | 0.21 X | |||
Book Value Per Share | (10.12) X | |||
Cash Flow From Operations | (12.59 M) | |||
Number Of Employees | 11 | |||
Total Asset | 1.19 M | |||
Retained Earnings | (26.39 M) | |||
Working Capital | (1.41 M) | |||
Net Asset | 1.19 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Bruush Stock
If you are still planning to invest in Bruush Oral Care check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bruush Oral's history and understand the potential risks before investing.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |